May 30, 2008
Cheaper Medicines for the Public Good
To the Editor:
Sheldon Elliot Steinbach's "Academe Should Oppose Speedier Approval of Generic Drugs" (The Chronicle, April 25) places universities' highly uncertain financial interests in technology licensing ahead of their public missions to promote the public good through, for example, ensuring that the fruits of university research are publicly available and affordable. If, as Steinbach recommends, universities support legislation to require long periods of marketing exclusivity for
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
Research
-
Faculty
-
Advice
